Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kostopoulos

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2020
Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse ModelEfthymios Paronis, Michalis Katsimpoulas, Nikolaos P E Kadoglou, et al.
Microorganisms|April 3, 2021
Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 InfectionIoannis V Kostopoulos, Nikolaos Orologas-Stavrou, Pantelis Rousakis, et al.
Blood|February 26, 2025
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myelomaEvangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, et al.
Proteomics|August 8, 2025
Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic RegimensFoteini Paradeisi, Aggeliki Tserga, Vasiliki Lygirou, et al.
Leukemia & Lymphoma|September 1, 2023
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantationEvangelos Eleutherakis Papaiakovou, Evangelos Terpos, Nikolaos Kanellias, et al.
Blood Advances|May 24, 2023
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesisAlexia Katsarou, Nikolaos Trasanidis, Kanagaraju Ponnusamy, et al.
Haematologica|February 15, 2024
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II studyEvangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, et al.
Haematologica|February 18, 2021
The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myelomaKanagaraju Ponnusamy, Maria Myrsini Tzioni, Murshida Begum, et al.
Cancers|November 14, 2019
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal DecapeptideAnastasios I Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, et al.
British Journal of Haematology|August 24, 2020
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significanceEfstathios Kastritis, Foteini Theodorakakou, Maria Roussou, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2020
Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse ModelEfthymios Paronis, Michalis Katsimpoulas, Nikolaos P E Kadoglou, et al.
Microorganisms|April 3, 2021
Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 InfectionIoannis V Kostopoulos, Nikolaos Orologas-Stavrou, Pantelis Rousakis, et al.
Blood|February 26, 2025
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myelomaEvangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, et al.
Proteomics|August 8, 2025
Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic RegimensFoteini Paradeisi, Aggeliki Tserga, Vasiliki Lygirou, et al.
Leukemia & Lymphoma|September 1, 2023
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantationEvangelos Eleutherakis Papaiakovou, Evangelos Terpos, Nikolaos Kanellias, et al.
Blood Advances|May 24, 2023
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesisAlexia Katsarou, Nikolaos Trasanidis, Kanagaraju Ponnusamy, et al.
Haematologica|February 15, 2024
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II studyEvangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, et al.
Haematologica|February 18, 2021
The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myelomaKanagaraju Ponnusamy, Maria Myrsini Tzioni, Murshida Begum, et al.
Cancers|November 14, 2019
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal DecapeptideAnastasios I Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, et al.
British Journal of Haematology|August 24, 2020
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significanceEfstathios Kastritis, Foteini Theodorakakou, Maria Roussou, et al.
Pageof 6